Jaguar Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	11.69	9.76	11.96	4.34	9.39	Upgrade
Revenue Growth (YoY)	19.75%	-18.36%	175.80%	-53.81%	62.51%	Upgrade
Cost of Revenue	1.96	2.04	2.02	2.33	3.16	Upgrade
Gross Profit	9.73	7.72	9.94	2	6.22	Upgrade
Selling, General & Admin	24.02	23.05	26.71	26	20	Upgrade
Research & Development	16.54	18.6	17.65	15.08	6.41	Upgrade
Operating Expenses	40.57	41.64	44.35	41.08	26.41	Upgrade
Operating Income	-30.83	-33.92	-34.42	-39.07	-20.19	Upgrade
Interest Expense	-0.23	-6.38	-12.72	-8.42	-2.79	Upgrade
Other Non Operating Income (Expenses)	-9.43	-4.93	0.93	-2.72	-2.51	Upgrade
EBT Excluding Unusual Items	-40.5	-45.23	-46.21	-50.21	-25.48	Upgrade
Asset Writedown	-	-0.37	-	-	-0.12	Upgrade
Other Unusual Items	1.25	3.7	-2.19	-2.39	-8.21	Upgrade
Pretax Income	-39.25	-41.9	-48.4	-52.6	-33.81	Upgrade
Earnings From Continuing Operations	-39.25	-41.9	-48.4	-52.6	-33.81	Upgrade
Minority Interest in Earnings	0.76	0.6	0.94	0.01	-	Upgrade
Net Income	-38.49	-41.3	-47.45	-52.6	-33.81	Upgrade
Preferred Dividends & Other Adjustments	-	-	-	-	4.84	Upgrade
Net Income to Common	-38.49	-41.3	-47.45	-52.6	-38.65	Upgrade
Shares Outstanding (Basic)	0	0	-	-	-	Upgrade
Shares Outstanding (Diluted)	0	0	-	-	-	Upgrade
Shares Change (YoY)	1809.95%	-	-	-	-	Upgrade
EPS (Basic)	-130.69	-2678.17	-	-	-	Upgrade
EPS (Diluted)	-130.69	-2678.17	-	-	-	Upgrade
Free Cash Flow	-29.4	-33.24	-33.18	-34.98	-15.29	Upgrade
Free Cash Flow Per Share	-99.82	-2155.63	-	-	-	Upgrade
Gross Margin	83.28%	79.13%	83.11%	46.18%	66.31%	Upgrade
Operating Margin	-263.76%	-347.50%	-287.85%	-901.36%	-215.09%	Upgrade
Profit Margin	-329.30%	-423.11%	-396.91%	-1213.26%	-411.81%	Upgrade
Free Cash Flow Margin	-251.52%	-340.56%	-277.53%	-806.83%	-162.87%	Upgrade
EBITDA	-28.93	-31.91	-32.43	-37.36	-18.46	Upgrade
EBITDA Margin	-247.51%	-	-271.28%	-	-196.69%	Upgrade
D&A For EBITDA	1.9	2.01	1.98	1.72	1.73	Upgrade
EBIT	-30.83	-33.92	-34.42	-39.07	-20.19	Upgrade
EBIT Margin	-263.76%	-	-287.85%	-	-215.09%	Upgrade
Revenue as Reported	11.69	9.76	-	4.34	-	Upgrade

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q